Valent BioSciences Files Patent Applications Claiming Benefits of Abscisic Acid in Animal Feed

FOR IMMEDIATE RELEASE

Studies show potential use for better health, growth, and feed conversion efficiencies.

LIBERTYVILLE, IL., February 16, 2012 – Valent BioSciences Corporation announced today it has filed worldwide patent applications claiming beneficial effects of an animal feed diet supplemented with abscisic acid (S-ABA). S-ABA is a naturally occurring substance found in all plants, including crops such as corn, wheat, and soybeans, as well as fruits and vegetables.

The patent applications cite new research that indicates a range of potential benefits resulting from the addition of S-ABA into poultry feed, including better overall health, improved weight gain, and enhanced feed conversion ratios.

“As the only global manufacturer and marketer of S-ABA, we’re excited to be further exploring potential commercial opportunities for both crop and non-crop uses with this molecule” said Warren E. Shafer, Valent BioSciences’ Vice President of Global Research & Development and Regulatory Affairs.

The filings are part of a series of global patents and patent applications sought by the Illinois-based biotechnology company, which has commercialized two products based on S-ABA for crop use in the last three years. ProTone® Plant Growth Regulator was launched in 2009 to enhance color in table grapes, while BioNikTM Plant Growth Regulator is being launched in 2012 as a seed treatment to extend the window of pollen shed in hybrid corn seed production.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in over 90 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
Barbara Wendling
Valent BioSciences Corporation
847-968-4793
Email: barbara.wendling@valentbiosciences.com

Download Press Release